| __timestamp | Amneal Pharmaceuticals, Inc. | BeiGene, Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 6930000 |
| Thursday, January 1, 2015 | 109679000 | 7311000 |
| Friday, January 1, 2016 | 118757000 | 20097000 |
| Sunday, January 1, 2017 | 109046000 | 62602000 |
| Monday, January 1, 2018 | 230435000 | 195385000 |
| Tuesday, January 1, 2019 | 289598000 | 388249000 |
| Wednesday, January 1, 2020 | 326727000 | 600176000 |
| Friday, January 1, 2021 | 365504000 | 990123000 |
| Saturday, January 1, 2022 | 399700000 | 1277852000 |
| Sunday, January 1, 2023 | 429675000 | 1504501000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. BeiGene, Ltd. and Amneal Pharmaceuticals, Inc. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses from 2014 to 2023.
BeiGene, a global biotechnology company, has seen its SG&A expenses skyrocket by over 21,500% from 2014 to 2023, reflecting its aggressive expansion and investment in research and development. In contrast, Amneal Pharmaceuticals, a more established player, has experienced a steady increase of about 400% in the same period, indicating a more measured approach to growth.
This divergence highlights the different strategies employed by these companies: BeiGene's rapid scaling versus Amneal's steady growth. Investors and industry analysts can glean valuable insights into the operational priorities and market positioning of these pharmaceutical giants.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and BeiGene, Ltd.
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
BeiGene, Ltd. and Exelixis, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Viking Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xencor, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.